Markets:

Overview

News

Currencies

International

Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

104.20 +1.62 (+1.58%)

Streaming Delayed Price Updated: 2:09 PM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Incyte Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

INCYTE CORP (NASDAQ:INCY), an undervalued stock with good fundamentals. ↗

May 08, 2025

INCYTE CORP may be an undervalued stock option. NASDAQ:INCY retains a strong financial foundation and an attractive price tag.

Via Chartmill

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 07, 2025

From Incyte

Via Business Wire

Incyte to Present at Upcoming Investor Conference

May 01, 2025

From Incyte

Via Business Wire

INCYTE CORP (NASDAQ:INCY) – A Look at Its Dividend Potential ↗

May 01, 2025

INCYTE CORP (NASDAQ:INCY) – A Look at Its Dividend Potential

Via Chartmill

Earnings Scheduled For April 29, 2025 ↗

April 29, 2025

Via Benzinga

9 Analysts Have This To Say About Incyte ↗

April 30, 2025

Via Benzinga

Discover the top S&P500 movers in Tuesday's after-hours session. ↗

April 29, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.

Via Chartmill

Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗

April 29, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

3 Value Stocks Facing Headwinds

April 29, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday? ↗

April 29, 2025

Wall Street modestly up as investors await economic data and corporate earnings. Bond market continues rally, gold and oil prices fall.Wall Street rises modestly, bond market continues rally, gold and...

Via Benzinga

Topics Bonds

Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers

April 29, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 19.5% year on year to $1.05 billion. Its non-GAAP profit...

Via StockStory

Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs

April 29, 2025

From Incyte

Via Business Wire

Incyte (INCY) Q1 Earnings Report Preview: What To Look For

April 28, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results tomorrow morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Government World Trade

Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025

April 25, 2025

From Incyte

Via Business Wire

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

April 23, 2025

From Incyte

Via Business Wire

INCYTE CORP (NASDAQ:INCY) is probably undervalued for the fundamentals it is displaying. ↗

April 15, 2025

Take a closer look at INCYTE CORP , a remarkable value stock. NASDAQ:INCY excels in fundamentals and maintains a very reasonable valuation.

Via Chartmill

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

April 15, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.

Via StockStory

Topics Artificial Intelligence

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

April 14, 2025

Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers.

Via StockStory

Topics Artificial Intelligence

Incyte to Report First Quarter Financial Results

April 10, 2025

From Incyte

Via Business Wire

What's going on in today's session: S&P500 movers ↗

April 09, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

April 09, 2025

Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.

Via Chartmill

Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday? ↗

April 09, 2025

Wall Street saw a tentative tech rebound early Wednesday, as investors begin to shrug off escalating U.S.-China trade tensions following a steep market selloff.

Via Benzinga

Topics World Trade

Explore the top gainers and losers within the S&P500 index in today's session. ↗

April 08, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Which S&P500 stocks are gapping on Tuesday? ↗

April 08, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 07, 2025

From Incyte

Via Business Wire

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

April 07, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Incyte (NASDAQ:INCY) and the best and worst...

Via StockStory

Topics Artificial Intelligence

Meta, AMD, Apple, AT&T Among Biggest US Tech Giants That 'May Suffer The Most' As Tariffs Spark Trade Turmoil: Here's Why ↗

April 03, 2025

Tariffs could heavily impact top tech beneficiaries of globalization as the cost of the goods sold by these firms may rise.

Via Benzinga

3 Reasons INCY is Risky and 1 Stock to Buy Instead

April 01, 2025

Over the past six months, Incyte’s shares (currently trading at $60.02) have posted a disappointing 11.8% loss while the S&P 500 was down 1.7%. This was partly driven by its softer quarterly results...

Via StockStory

Topics Stocks

XPeng, Reddit And Micron Tech Are Among Top 10 Large-Cap Losers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio? ↗

March 23, 2025

Large-cap stocks worst performers last week, including BEKE, RDDT, FUTU, JHX, INCY, NUE, BAH, XPEV, MRNA, TU, WLK. Are they in your portfolio?

Via Benzinga

What's going on in today's session: S&P500 movers ↗

March 21, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.